Emerson Reports Fourth Quarter and Full Year 2025 Results;
Provides Initial 2026 Outlook

ST. LOUIS (November 5, 2025) - Emerson (NYSE: EMR) today reported results1 for its fourth quarter and fiscal year ended September 30, 2025. Emerson also declared a 5% quarterly cash dividend increase to $0.555 per share of common stock payable December 10, 2025 to stockholders of record November 14, 2025. Additionally, Emerson announced that its Board of Directors authorized the company to repurchase up to 50 million shares of its common stock. This is in addition to the authorization approved in March 2020, to repurchase 60 million shares of common stock, which has approximately 20 million shares remaining.

"Emerson delivered a solid fiscal 2025, marked by continued margin expansion, robust cash generation and strong execution. The dedication of our global teams was instrumental in driving our performance and advancing Emerson's position as the leading automation company," said Emerson President and Chief Executive Officer Lal Karsanbhai. "We are proud of the meaningful progress we have made integrating AspenTech and of completing the Test & Measurement integration – delivering on our commitment to achieve $200M of run-rate cost synergies."

Karsanbhai continued, “Our portfolio is aligned with long-term secular trends positioned to drive sustainable growth into the future. These trends have driven mid-single-digit underlying orders growth for three consecutive quarters, supporting our sales expectations for 2026 and beyond. We remain confident in our operational execution and ability to return cash to shareholders, accelerating further value creation."

The following tables summarize the fiscal year 2026 guidance framework. As we pivot capital allocation to returning cash to shareholders, the 2026 outlook assumes returning ~$2.2B through ~$1B of share repurchases and ~$1.2B of dividends.

			2026 Q1			2026
Net Sales Growth			~4%			~5.5%
Underlying Sales Growth			~2%			~4%
Earnings Per Share			~$0.98			$4.73 - $4.93
Amortization of intangibles			~$0.35			~$1.42
Restructuring and related costs			~$0.05			~$0.15
Acquisition/divestiture fees and related costs			~$0.02			~$0.05
Adjusted Earnings Per Share			~$1.40			$6.35 - $6.55
Operating Cash Flow						$4.0B - $4.1B
Free Cash Flow						$3.5B - $3.6B
Share Repurchase						~$1.0B

1 Results are presented on a continuing operations basis.

2 Underlying orders do not include AspenTech.

3 Underlying sales exclude the impact of currency translation, and significant acquisitions and divestitures.

4 Adjusted segment EBITA represents segment earnings less restructuring and intangibles amortization expense.

5 Adjusted EPS excludes intangibles amortization expense, restructuring and related costs, acquisition/divestiture gains, losses, fees and related costs, and discrete taxes.

Today, beginning at 7:30 a.m. Central Time / 8:30 a.m. Eastern Time, Emerson management will discuss the fourth quarter and fiscal year 2025 results during an investor conference call. Participants can access a live webcast available at https://ir.emerson.com at the time of the call. A replay of the call will be available for 90 days. Conference call slides will be posted in advance of the call on the company website.

Emerson will hold an in-person and virtual investor conference on Thursday, Nov. 20 in New York City. A live webcast of the investor conference will begin at 8:00 a.m. Central Time / 9:00 a.m. Eastern Time. A link to register and attend the webcast is available at https://ir.emerson.com/. The webcast will remain available for 90 days.

Emerson (NYSE: EMR) is a global industrial technology leader that provides advanced automation. With an unmatched portfolio of intelligent devices, controls systems, and industrial software, Emerson delivers solutions that automate and optimize business performance. Headquartered in Saint Louis, Missouri, Emerson combines innovative technology with proven operational excellence to power the future of automation. For more information, visit Emerson.com.

Statements in this press release that are not strictly historical may be “forward-looking” statements, which represent management’s expectations, based on currently available information. Actual results, performance or achievements could differ materially from those expressed in any forward-looking statement. Any forward-looking statements in this press release speak only as of the date of this press release. Emerson undertakes no obligation to update any such statements to reflect new information or later developments. Examples of risks and uncertainties that may cause our actual results or performance to be materially different from those expressed or implied by forward looking statements include the scope, duration and ultimate impacts of the Russia-Ukraine and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company's expectation for its consolidated results, other than as noted herein.

Emerson uses our Investor Relations website, https://ir.emerson.com, as a means of disclosing information

which may be of interest or material to our investors and for complying with disclosure obligations under Regulation

FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases,

SEC filings, public conference calls, webcasts and social media. The information contained on, or that may be

accessed through, our website is not incorporated by reference into, and is not a part of, this document.

(tables attached)

																					Table 1
EMERSON AND SUBSIDIARIES
CONSOLIDATED OPERATING RESULTS
(AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)
			Quarter Ended September 30,												Year Ended September 30,
			2024						2025						2024						2025
Net sales			$	4,619					$	4,855					$	17,492					$	18,016
Costs and expenses:
Cost of sales			2,248						2,335						8,607						8,497
SG&A expenses			1,315						1,330						5,142						5,103
Gain on subordinated interest			—						—						(79)						—
Loss on Copeland note receivable			—						—						279						—
Other deductions, net			359						302						1,434						1,245
Interest expense, net			18						92						175						237
Interest income from related party1			—						—						(86)						—
Earnings from continuing operations before income taxes			679						796						2,020						2,934
Income taxes			149						160						415						696
Earnings from continuing operations			530						636						1,605						2,238
Discontinued operations, net of tax			438						1						350						8
Net earnings			968						637						1,955						2,246
Less: Noncontrolling interests in subsidiaries			(28)						—						(13)						(47)
Net earnings common stockholders			$	996					$	637					$	1,968					$	2,293
Earnings common stockholders
Earnings from continuing operations			$	558					$	636					$	1,618					$	2,285
Discontinued operations			438						1						350						8
Net earnings common stockholders			$	996					$	637					$	1,968					$	2,293
Diluted avg. shares outstanding			573.9						565.5						574.0						566.7
Diluted earnings per share common stockholders
Earnings from continuing operations			$	0.97					$	1.12					$	2.82					$	4.03
Discontinued operations			0.76						—						0.61						0.01
Diluted earnings per common share			$	1.73					$	1.12					$	3.43					$	4.04
			Quarter Ended September 30,												Year Ended September 30,
			2024						2025						2024						2025
Other deductions, net
Amortization of intangibles			$	266					$	208					$	1,077					$	884
Restructuring costs			58						66						228						136
Other			35						28						129						225
Total			$	359					$	302					$	1,434					$	1,245
1 Represents interest on the Copeland note receivable.

The following tables show results for the Company's segments on an adjusted segment EBITA basis and are intended to supplement the Company's results of operations, including its segment earnings which are defined as earnings before interest and taxes. The Company defines adjusted segment and total segment EBITA as segment earnings excluding intangibles amortization expense, and restructuring and related expense. Adjusted segment and total segment EBITA, and adjusted segment and total segment EBITA margin are measures used by management and may be useful for investors to evaluate the Company's segments' operational performance.

The following table shows the Company's stock compensation and corporate and other expenses on an adjusted basis. The Company's definition of adjusted stock compensation excludes integration-related stock compensation expense. The Company's definition of adjusted corporate and other excludes corporate restructuring and related costs, first year purchase accounting related items and transaction fees, and certain gains, losses or impairments. These metrics are useful for reconciling from total adjusted segment EBITA to the Company's consolidated adjusted EBITA.

The following tables, which show results on an adjusted EBITA basis and diluted earnings per share on an adjusted basis, are intended to supplement the Company's discussion of its results of operations herein. The Company defines adjusted EBITA as earnings excluding interest expense, net, income taxes, intangibles amortization expense, restructuring expense, first year purchase accounting related items and transaction fees, and certain gains, losses or impairments. Adjusted earnings per share excludes intangibles amortization expense, restructuring expense, first year purchase accounting related items and transaction-related costs, and certain gains, losses or impairments. Adjusted EBITA, adjusted EBITA margin, and adjusted earnings per share are measures used by management and may be useful for investors to evaluate the Company's operational performance.

Reconciliations of Non-GAAP Financial Measures & Other

Table 7

Reconciliations of Non-GAAP measures with the most directly comparable GAAP measure (dollars in millions, except per share amounts). See tables 4 through 7 for additional non-GAAP reconciliations.

Q4 FY25 Underlying Sales Change			Reported			(Favorable) / Unfavorable FX			(Acquisitions) / Divestitures			Underlying
Final Control			4		%	(1)		%	—		%	3		%
Measurement & Analytical			3		%	(1)		%	—		%	2		%
Discrete Automation			5		%	(1)		%	—		%	4		%
Safety & Productivity			2		%	(1)		%	—		%	1		%
Intelligent Devices			4		%	(1)		%	—		%	3		%
Control Systems & Software			7		%	(1)		%	—		%	6		%
Test & Measurement			13		%	(1)		%	—		%	12		%
Software and Control			9		%	(1)		%	—		%	8		%
Emerson			5		%	(1)		%	—		%	4		%

Free Cash Flow						FY24			FY25						2026E ($ in billions)
Operating cash flow (GAAP)						$	3,317		$	3,676					$4.0 - $4.1
Capital expenditures						(419)			(431)						~(0.45)
Free cash flow (non-GAAP)						$	2,898		$	3,245					$3.5 - $3.6

Note 1: Underlying sales and orders exclude the impact of currency translation and significant acquisitions and divestitures.

Note 2: All fiscal year 2026E figures are approximate, except where range is given.